ProMIS Neurosciences, Inc. (PMN) Earnings History
Net Loss20 years of earnings data (2006–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
ProMIS Neurosciences, Inc. (PMN) Earnings Overview
As of July 7, 2026, ProMIS Neurosciences, Inc. (PMN) reported trailing twelve-month net income of -$41M, reflecting -922.2% year-over-year growth. The company earned $-6.22 per diluted share over the past four quarters.
Looking at the long-term picture, PMN's historical earnings data spans multiple years. The company achieved its highest annual net income of $3M in fiscal 2024.
ProMIS Neurosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PRTA (-$151M net income, -2520.6% margin), ARVN (-$221M net income, -30.8% margin), ACAD ($376M net income, 36.5% margin), PMN has comparable earnings metrics. Compare PMN vs PRTA →
PMN Earnings vs Peers
Earnings metrics vs comparable public companies
PMN Historical Earnings Data (2006–2025)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$40M | -1529.3% | -$40M | $-22.61 | - | - |
| 2024 | $3M | +115.9% | -$17M | $2.75 | - | - |
| 2023 | -$18M | +3.1% | -$19M | $-35.50 | - | - |
| 2022 | -$18M | -87.0% | -$23M | $-42.50 | - | - |
| 2021 | -$10M | -70.6% | -$8M | $-41.75 | -118657.8% | -101359.8% |
| 2020 | -$6M | +23.4% | -$6M | $-23.25 | -361814.2% | -361814.2% |
| 2019 | -$7M | +0.9% | -$12M | $-32.75 | -615329.4% | -1009282.5% |
| 2018 | -$7M | -55.9% | -$7M | $-46.75 | -2138862.5% | -2138862.5% |
| 2017 | -$5M | -86.2% | -$5M | $-35.00 | -60836.9% | -60765.1% |
| 2016 | -$3M | -68.2% | -$3M | $-22.75 | -128395.4% | -127804.9% |
| 2015 | -$2M | +25.0% | -$2M | $-21.25 | -10639.8% | -10519.5% |
| 2014 | -$2M | +7.0% | -$2M | $-50.50 | -1519.2% | -1519.2% |
| 2013 | -$2M | +14.0% | -$2M | $-58.00 | -4505.5% | -4510.2% |
| 2012 | -$3M | +25.6% | -$3M | $-74.75 | -2799.0% | -2813.9% |
| 2011 | -$3M | +28.1% | -$3M | $-105.25 | -278.4% | -278.4% |
| 2010 | -$5M | -16.9% | -$5M | $-149.75 | -2704.7% | -2704.7% |
| 2009 | -$4M | +41.6% | -$4M | $-145.75 | -2105.6% | -2105.6% |
| 2008 | -$7M | -90.3% | -$7M | $-253.75 | -1505.4% | -1505.4% |
| 2007 | -$4M | -117.5% | -$4M | $-173.25 | -1668.8% | -1668.8% |
| 2006 | -$2M | - | -$2M | $-131.00 | -5388.2% | -5382.9% |
Download Data
Export PMN earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
20+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PMN — Frequently Asked Questions
Quick answers to the most common questions about buying PMN stock.
What is PMN earnings per share (EPS)?
PMN trailing twelve-month (TTM) diluted EPS is $-6.22, reflecting -922.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2006 to 2025 is available in the table on this page.
What is ProMIS Neurosciences, Inc.'s net income?
ProMIS Neurosciences, Inc. (PMN) trailing twelve-month net income is $-41M as of 2025. Earnings declined -922.2% year-over-year.
Is PMN profitable?
PMN is not currently profitable on a TTM basis, reporting a net loss of $-41M. Net margin is N/A. Investors should monitor for a return to profitability.
What is PMN's earnings growth rate?
PMN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2006 to 2025.
What are PMN's profit margins?
ProMIS Neurosciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -521.6%.
Is PMN growing earnings?
PMN earnings are declining — EPS fell -922.2% year-over-year. TTM net income dropped to $-41M. This contrasts with the 5-year CAGR of N/A.
What was PMN's best earnings year?
ProMIS Neurosciences, Inc.'s highest annual net income on record is $3M, achieved in fiscal year 2024. Earnings history on this page spans 2006 to 2025 and includes all annual and quarterly figures.
What were PMN's earnings last quarter?
PMN's most recent reported quarter was Q1 2026. Net income was $-8M with diluted EPS of $-1.26. For a full breakdown of all quarters, see the quarterly earnings table on this page.